MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.
Issue link: https://medesthetics.epubxp.com/i/123304
NEWS & EVENTS Jackson, Mississippi • Julie A. Hodge, MD, MPH, FAAD, assistant clinical professor at the University of California at Irvine • George J. Hruza, MD, MBA, FAAD, clinical professor of dermatology and otolaryngology at St. Louis University • Paul Storrs, MD, FAAD, a dermatologist in private practice in Palos Heights, Illinois and former director of dermatologic surgery at the University of Illinois College of Medicine in Chicago. VALEANT TO ACQUIRE OBAGI Valeant Pharmaceuticals International has entered into a definitive agreement to acquire Obagi Medical Products. Under the terms of the agreement, Valeant will acquire all of the outstanding common stock of Obagi Medical Products for $24 per share in cash. The transaction is expected to close in the first half of 2013. Obagi Medical Products is a leader in topical aesthetic and therapeutic skin health systems with a product portfolio that includes leading dermatology brands Obagi Nu-Derm, Condition & Enhance, Obagi-C Rx, ELASTIDerm and CLENZIDerm. "The acquisition of Obagi will be a valuable supplement to Valeant's current dermatology portfolio and will further build upon our growing aesthetics franchise," said J. Michael Pearson, chairman and CEO of Valeant. "Obagi is a leader in the physician-dispensed market and enjoys a strong brand perception among physicians. The addition of their products will not only strengthen and diversify our dispensed portfolio, but also expand our market presence with dermatologists and plastic surgeons." NUVO RESEARCH LAUNCHES PLIAGLIS BY GALDERMA IN U.S. Nuvo Research (nuvoresearch.com), a specialty pharmaceutical company devoted to topical pain treatment, has licensed worldwide marketing rights for Pliaglis Whatever you need, we've got you covered Cream to Galderma, a pharmaceutical company specializing in dermatology. Pliaglis is a topical local anesthetic cream (lidocaine and tetracaine 7%) that uses Nuvo's proprietary phase-changing technology to form a pliable peel on the skin when exposed to air. Pliaglis is indicated for use on intact skin in adults to provide local analgesia for superficial aesthetic procedures, such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing and laser-assisted tattoo removal. "The introduction of Pliaglis marks the next stage of Galderma's growth in the aesthetic and corrective area," says Francois Fournier, president of Galderma. "Galderma is more than ever committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals." SKIN OF COLOR SOCIETY PRESIDENT ELECTED Marta I. Rendon, MD, was unanimously elected as the president of the Skin of Color Society by her medical colleagues at the 2013 American Academy of Dermatology meeting in Miami. The Skin of Color Society is committed to the education of healthcare providers and the general public on dermatologic health issues related to skin of color, which is defined by the Society as individuals who are of Asian, Latino, African, Native American and Pacific Island descent. Dr. Rendon is a world-renowned, board-certified dermatologist and the founder of the Rendon Center for Dermatology & Aesthetic Medicine in Boca Raton, Florida. AMBI DONATES $15,000 FOR SKIN OF COLOR SOCIETY RESEARCH AWARD With our 3 creamy mineral foundations each with soothing zinc oxide, SPF 20, superior coverage and a natural looking fnish 1-916-939-9888 1-800-476-0226 toll free w w w. i l l u m i n a re c o s m e t i c s . c o m 66 MAY/JUNE 2013 | MedEsthetics AMBI Skincare has donated $15,000 in support of an annual grant that promotes dermatology research within the field of skin of color. The grant will assist a young dermatologist, resident or physician within five years of graduation in furthering his or her academic career. Requirements include a strong commitment to research within